Barnes Hospital Bulletin

Barnes Hospital Bulletin

Barnes Hospital, St. Louis, Mo. April, 1984, Vol. XXXVIII, No. 4 Auxiliary celebrates 25th anniversary Twenty-five years of dedicated service and finan- cial support will be celebrated by the Barnes Hos- pital Auxiliary at its annual spring luncheon and business meeting April 26. Elaine Viets, a feature columnist with the St. Louis Post-Dispatch, will be the guest speaker. The Auxiliary's annual meeting begins at 11 a.m., with a cash bar and the silver anniversary lun- cheon following. The event is being held at the Radisson Hotel, Ninth Street and Convention Plaza. One of the afternoon's highlights will be the pre- sentation of a check by Auxiliary president Mary M Ann Fritschle to Barnes board of directors chair- man Harold E. Thayer representing the Auxiliary's final installment of a $1 million pledge, made in 1981, to help finance the construction of new trau- ma center facilities at Barnes. The Auxiliary has already donated $685,000 to the project, which should be completed in early 1985. Before: A blockage in a coronary artery cuts off the sup- After: A new drug, t-PA, moves directlym to the clot and Since its inception in 1959, the Auxiliary, frequent- ply of oxygen-rich blood to the heart muscle. A heart dissolves the blockage, re-establishing blood flow to ly named as the top such organization in the state, attack results. the heart muscle. has given $3,260,723.72 to Barnes. The Auxiliary makes its yearly donations to the hospital through its sponsorship of the Wishing Well Gift and Flower Drug researched here least two ways: (1) by harvesting a human tissue Shops, Nearly New Shop, Tribute Fund and Baby culture system through a lengthy and expensive Photo Service. The 665-member Auxiliary also may prevent heart attack process of extraction and purification (to produce coordinates the hospital's highly successful volun- the amount of t-PA necessary to treat one heart A new drug, tissue plasminogen activator (t-PA), teer services program, whose 460 volunteers pro- attack victim, two technicians must work full-time vided 50,809 hours of service in 1983. researched by Barnes Hospital/Washington Uni- over three to four weeks); (2) by genetically en- versity School of Medicine staff members, may gineering it through a process developed last year. save as many as 100,000 to 200,000 lives each year in the United States alone by dissolving the T-PA dissolves a blood clot which is causing a 1983 Annual Report biood clots which cause heart attacks, according heart attack. Administered intravenously, during highlights mission to a published report in the March 8 issue of The the early stages (the first one to two hours) of an New England Journal of Medicine. attack, it circulates in the bloodstream but is, in Barnes' 1983 Annual Report, published this biological terms, relatively inactive until it comes month, highlights the sweeping changes in tech- Last September, Barnes/WU researchers received into contact with a clot. There it activates the nology and the delivery of health care that have FDA approval to conduct the world's first clinical body's natural clot-dissolving reaction in the imme- occurred during the past year and outlines the ad- trial of t-PA on human patients in the early stages diate vicinity of the clot, thus stopping the attack, vances that are enabling Barnes to continue ful- of heart attack. In six of seven patients studied, usually within seven to 30 minutes after injection. filling its mission as one of the world's pre-eminent t-PA stopped the attack within minutes by dissolv- Blood flow resumes to areas beyond the clot de- providers of health care. ing the blood clot that was causing it and restoring prived of blood during the attack. blood flow to the tissue beyond, without putting the The report also describes Barnes' role as a na- patient at risk of bleeding elsewhere in the body. T-PA may become an important form of early treat- tional resource for health care and education and ment for suspected or incipient heart attack pa- the institution's increasing responsibility as a major For several years, Barnes Hospital and Washing- tients. It dissolves the clot selectively, without pro- midwestern referral center. It is divided into seven ton University School of Medicine have played a ducing a tendency to bleeding elsewhere in the major sections, including technology, cancer ther- critical role in t-PA research. The center is the first body ("systemic lytic state"). Streptokinase and apy, VIP services, facilities, community outreach, in the world at which t-PA was used to dissolve urokinase, two other clot-dissolving drugs, both people/finances and future plans. clots causing heart attacks in animals. It is also the produce a systemic lytic state and therefore put Nuclear magnetic resonance, ophthalmology's first, in collaboration with a Belgian center, at the patient at risk of serious bleeding. And with its YAG laser, chemonucleolysis for dissolving herni- which the drug was used on human patients. It is low risk, emergency personnel, even heart disease ated discs in the lumbar spine, percutaneous the first to publish work which reported that genet- patients themselves, may ultimately inject t-PA nephrolithotripsy or the use of ultrasound to re- ically engineered t-PA had dissolved coronary ar- when a heart attack is suspected. tery clots in animals. The center is participating in move kidney stones, microsurgery and strepto- on-going clinical studies of t-PA, in combination It is possible, researchers say, that of the 400,000 kinase/t-PA infusion to reduce the amount of heart with other centers and with the National Institutes to 500,000 deaths from heart attack in the U.S. tissue muscle death during heart attack are just of Health. each year, some 100,000 to 200,000 lives might some of the technological advances, many of be saved through t-PA. For some patients, other which have been partially developed here, that are T-PA is an enzyme naturally occurring in the cells forms of treatment will still be required. But even a giving Barnes patients new hope for a normal life that line blood vessels. It can be produced in at cautious evaluation indicates that "in the relatively and are capsulized in the 1983 Annual Report. near future, t-PA will become part of general med- ical practice in the treatment of heart attack. It The report also features the multitude of advances Front cover: In the fight against cancer, new laboratory should definitely save the lives of many patients," that have taken place here in cancer therapy, in- techniques are enabling doctors to detect disease cluding the liver pump, which allows potent can- sooner and diagnose it more accurately, while medical says Dr. Burton E. Sobel, Barnes Hospital cardi- ologist-in-chief and director of the cardiovascular cer-fighting drugs to be infused directly into the and surgical advances in cancer treatment and man- liver, Moh's chemosurgery for facial cancers, agement are giving many victims hope for a cure. (See division at Washington University School of Medi- centerspread.) cine. (continued on page 2) emotional support and information during their Annual Report hospitalization for mastectomy, the surgical re- (continued from page 1) moval or partial removal of the diseased breast. nerve-sparing prostate surgery that preserves po- tency in men with bladder or prostate cancer, During this critical time, volunteers, all former mas- hyperthermia for superficial tumors of the head tectomy patients who have received special train- and neck, breast or chest wall and new tech- ing from the ACS, visit patients and share their re- **m niques in surgical pathology that are detecting lated experiences. Information is also given on v cancer sooner and more precisely than previously breast prosthesis, shopping for clothes, exercise nT * possible. and other tips. Patients are referred to RTR volun- teers by their doctors. ^^ Statistics in the Annual Report show that 37,276 S.H.A.R.E. (Support Has A Reinforcing Effect) is a patients were admitted resulting in an occupancy breast cancer support group that was started at rate of 82.35 percent for the hospital's 1,158 beds m Barnes in 1981 and provides ongoing support in use. (Barnes holds licensure for 1,208 beds.) through monthly meetings, newsletters, small in- Barnes also had 31,620 emergency department formal group sessions, a hotline and a lending - visits; 29,392 surgical procedures (up from 28,977 Ms i/JM library. Two S.H.A.R.E. publications, "Coping with in 1982) and 2,792 babies delivered. The total bud- ■ Breast Cancer—Strategies for Dealing with the get for 1983 was $188,667,660. Limitations, Problems and Discomforts of Breast Cancer" and "Breast Cancer Resources for Pa- Wages and benefits accounted for 49 cents of tients and Families" are also available, while car- every dollar, while 32 cents of each dollar was pool and mailing services provide transportation to spent on medicines and supplies. Other expenses and from meetings and keep those unable to at- IK include food, insurance, repairs, depreciation, tend meetings in touch. John Keppel retires after 30 years of service maintenance and utilities. S.H.A.R.E. members also sponsor an annual Since Barnes receives no government or tax sup- breast cancer educational conference that fea- port, the hospital's inpatients constitute its major Keppel, Telthorst, tures speakers from the medical profession and, source of income, contributing 83 cents of every along with RTR volunteers, they are actively in- Thurman retire dollar of revenue. Other sources of income in- volved in community health fairs.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    8 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us